The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Align Technology Inc

Nasdaq: ALGN
Last

(U.S.) $186.24

Today's change-2.10 -1.11%
Updated September 19 11:15 AM EDT. Delayed by at least 15 minutes.
 

Align Technology Inc

Nasdaq: ALGN
Last

(U.S.) $186.24

Today's change-2.10 -1.11%
Updated September 19 11:15 AM EDT. Delayed by at least 15 minutes.

Reversal following new 100-day high

Align Technology Inc is lower today, dropping (U.S.)$2.10 or 1.11% to (U.S.)$186.24 after setting a new 100-day high. Over the last five days, shares have gained 0.31% and are currently 2.00% off of the 52-week high. Shares have outperformed the S&P 500 by 80.79% during the last year.

Key company metrics

  • Open(U.S.) $189.07
  • Previous close(U.S.) $188.34
  • High(U.S.) $190.04
  • Low(U.S.) $186.04
  • Bid / Ask(U.S.) $186.18 / (U.S.) $186.33
  • YTD % change+93.74%
  • Volume180,910
  • Average volume (10-day)952,255
  • Average volume (1-month)933,400
  • Average volume (3-month)1,115,825
  • 52-week range(U.S.) $83.27 to (U.S.) $190.04
  • Beta1.55
  • Trailing P/E63.90×
  • P/E 1 year forward55.37×
  • Forward PEG2.16×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.91
Updated September 19 11:15 AM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+19.59%

Based on its net profit margin of 19.59%, Align Technology Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.34%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue356310293279
Total other revenue--------
Total revenue356310293279
Gross profit271236220209
Total cost of revenue86757369
Total operating expense273249225217
Selling / general / administrative163151130127
Research & development24232220
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income84626862
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax87636164
Income after tax71714952
Income tax, total15-71212
Net income69694851
Total adjustments to net income--------
Net income before extra. items69694851
Minority interest--------
Equity in affiliates-2-1-10
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items69694851
Inc. avail. to common incl. extra. items69694851
Diluted net income69694851
Dilution adjustment--------
Diluted weighted average shares82828181
Diluted EPS excluding extraordinary itemsvalue per share0.850.850.590.63
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.850.850.590.63